CBD Drug Co. Alleges Teva, Others Violated Patents

By Sam Reisman · January 5, 2023, 6:48 PM EST

British pharmaceutical firm GW Pharmaceuticals has accused a dozen drug manufacturers, including Teva Pharmaceuticals, of violating its patents when they sought approval to sell generic versions of the company's flagship CBD-derived...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al

Case Number

2:23-cv-00018

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

January 03, 2023